EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor

Andrea Piserchio, Eta A Isiorho, Kevin N Dalby, Ranajeet Ghose

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Andrea Piserchio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The City College of New York, New York, New York, USA. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Calmodulin, Elongation Factor 2 Kinase. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Brookhaven National Laboratory, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The calmodulin-activated α-kinase, eukaryotic elongation factor 2 kinase (eEF-2K), serves as a master regulator of translational elongation by specifically phosphorylating and reducing the ribosome affinity of the guanosine triphosphatase, eukaryotic elongation factor 2 (eEF-2). Given its critical role in a fundamental cellular process, dysregulation of eEF-2K has been implicated in several human diseases, including those of the cardiovascular system, chronic neuropathies, and many cancers, making it a critical pharmacological target. In the absence of high-resolution structural information, high-throughput screening efforts have yielded small-molecule candidates that show promise as eEF-2K antagonists. Principal among these is the ATP-competitive pyrido-pyrimidinedione inhibitor, A-484954, which shows high specificity toward eEF-2K relative to a panel of "typical" protein kinases. A-484954 has been shown to have some degree of efficacy in animal models of several disease states. It has also been widely deployed as a reagent in eEF-2K-specific biochemical and cell-biological studies. However, given the absence of structural information, the precise mechanism of the A-484954-mediated inhibition of eEF-2K has remained obscure. Leveraging our identification of the calmodulin-activatable catalytic core of eEF-2K, and our recent determination of its long-elusive structure, here we present the structural basis for its specific inhibition by A-484954. This structure, which represents the first for an inhibitor-bound catalytic domain of a member of the α-kinase family, enables rationalization of the existing structure-activity relationship data for A-484954 variants and lays the groundwork for further optimization of this scaffold to attain enhanced specificity/potency against eEF-2K.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine TriphosphateCalmodulinElongation Factor 2 KinaseAnimalsHumansPeptide Elongation Factor 2PhosphorylationCatalytic DomainStructure-Activity RelationshipPeptide Chain Elongation, TranslationalPyridinesPyrimidines

Stichwörter der Autor:innen

ATP-competitive kinase inhibitoralpha-kinaseatypical kinasecalmodulin-dependent kinaseeukaryotic elongation factor 2 kinaseprotein translation

Substanzen

Adenosine TriphosphateCalmodulinElongation Factor 2 KinasePeptide Elongation Factor 2EEF2K protein, humanA-484954PyridinesPyrimidines

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, The City College of New York, New York, New York, USA.
  • Macromolecular Crystallization Facility, CUNY ASRC, New York, New York, USA.
  • Division of Chemical Biology and Medicinal Chemistry, The University of Texas, Austin, Texas, USA; Interdisciplinary Life Sciences Graduate Program, The University of Texas, Austin, Texas, USA. Electronic address: dalby…
  • Department of Chemistry and Biochemistry, The City College of New York, New York, New York, USA; PhD Program in Biochemistry, The Graduate Center of CUNY, New York, New York, USA; PhD Program in Chemistry, The Graduate…

Förderung

  • NIGMS NIH HHS
  • Brookhaven National Laboratory
  • National Institutes of Health
  • U.S. Department of Energy
  • Welch Foundation
  • Cancer Prevention and Research Institute of Texas
  • Office of Science

Zitieren

APA

Piserchio, A., Isiorho, E. A., Dalby, K. N., & Ghose, R. (2023). Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104813

Vancouver

Piserchio A, Isiorho EA, Dalby KN, Ghose R. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104813

BibTeX
@article{Piserchio2023,
  author = {Piserchio, Andrea and Isiorho, Eta A and Dalby, Kevin N and Ghose, Ranajeet},
  title = {Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104813}
}
Kostenlos starten →